← Patent-cliff monitor Loss of exclusivity June 2036 latest FDA-listed patent expiry
Drug detail Brand name DESCOVY Active ingredient EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE Strength 120MG;EQ 15MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval January 2022 Marketing status RX
Listed patents Patent Expires Type 12661323 June 2036 product 8754065*PED February 2033 — 9296769*PED February 2033 — 8754065 August 2032 substance, product 9296769 August 2032 substance, product
Regulatory exclusivity Code Expires ODE-556 June 2032 ODE-554 January 2029 ODE-457 January 2029 M-316 June 2028
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.